China Sxt Pharmaceuticals (SXTC) on Tuesday filed a statement to register the resale of up to 157.5 million Class A ordinary shares by selling shareholder Smart Mart.
The shares may be issued under a July 3 securities purchase agreement that provides for up to $31.5 million in prepaid purchases.
The company said it will not receive any proceeds from the resale of shares by the selling shareholder.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.